Insmed Incorporated [NASDAQ: INSM] dipped by -2.03% on the last trading session, reaching $18.82 price per share at the time. Insmed Incorporated represents 89.73M in outstanding shares, while the company has a total market value of $1.72B with the latest information.
The Insmed Incorporated traded at the price of $18.82 with 866140 shares were bought and sold during the latest trading session. Over the period of the last 3 months, the average trading volume of INSM shares recorded 1.18M.
Insmed Incorporated [NASDAQ:INSM]: Analyst Rating and Earnings
Its stock price has been found in the range of 11.31 to 33.13. This is compared to its latest closing price of $19.21.
Pay attention for this company’s financial results, of which the next release is scheduled to happen on Tue 29 Oct (In 47 Days).
Fundamental Analysis of Insmed Incorporated [INSM]
Now let’s turn to look at profitability: with a current Operating Margin for Insmed Incorporated [INSM] sitting at -3124.94 and its Gross Margin at +26.29.
This company’s Return on Total Capital is -65.29, and its Return on Invested Capital has reached -59.00%. Its Return on Equity is -113.92, and its Return on Assets is -60.81. These metrics suggest that this Insmed Incorporated does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, Insmed Incorporated [INSM] has generated a Total Debt to Total Equity ratio of 152.00. Similarly, its Total Debt to Total Capital is 60.32, while its Total Debt to Total Assets stands at 52.36. Looking toward the future, this publicly-traded company’s
What about valuation? This company’s Enterprise Value to EBITDA is -4.43. The Enterprise Value to Sales for this firm is now 21.74, and its Total Debt to Enterprise Value stands at 0.38. Insmed Incorporated [INSM] has a Price to Book Ratio of 4.87.
Shifting the focus to workforce efficiency, Insmed Incorporated [INSM] earns $26,367 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.57 and its Total Asset Turnover is 0.02. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 6.42 and its Current Ratio is 6.51. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Insmed Incorporated [INSM] has 89.73M shares outstanding, amounting to a total market cap of $1.72B. Its stock price has been found in the range of 11.31 to 33.13. At its current price, it has moved down by -43.19% from its 52-week high, and it has moved up 66.40% from its 52-week low.
This stock’s Beta value is currently 2.98, which indicates that it is 5.55% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 58.95. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Insmed Incorporated [INSM] a Reliable Buy?
Shares of Insmed Incorporated [INSM], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.